Aveanna Healthcare Holdings (Nasdaq: AVAH) expects 5% to 7% company-wide growth in the coming year, achieving through a five-pronged strategy. These efforts include strengthening relationships with payers, finding opportunities to reduce costs, modernizing its medical solutions services, optimizing capital structure and cash flow, and increasing engagement among staff and leadership. Aveanna’s preferred-payer and government affairs […]
Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has a strong appetite for acquisitions, but has held off due to high valuations in the hospice space and uncertain home health reimbursement rates. Aveanna provides hospice, home health and private duty care services. The company sees positive growth momentum heading into the final months of 2025, Aveanna CEO […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is hungry for acquisitions, but hospice transactions are likely not on the menu. Aveanna’s expanding hospice and home health business has largely included a focus on organic growth and tuck-ins across its existing geographic markets. Acquisitions could make up a larger portion of its strategy on the near horizon, according […]
Issues surrounding Medicare fraud are “top of mind” for hospice providers, according to Jim Melancon, senior vice president of government affairs at Aveanna Healthcare Holdings (Nasdaq: AVAH). Reports of hospice fraud have proliferated in recent years, particularly in the four hotbed states of California, Arizona, Nevada and Texas. Fraudulent operators have used a slew of […]
Hospice has emerged as a growth engine for publicly traded home-based care companies, several of which are on the hunt for acquisitions. Hospice has buoyed growth for several companies as they battle home health-related headwinds, including reimbursement pressures. Companies like VITAS Healthcare, which only provide hospice and palliative care, also saw substantial growth. VITAS is […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is propelling growth of its home health and hospice segment through strategic payer relationships, bolstered sales and referral teams and a growing patient census. Aveanna’s has seen consecutive periods of slow but steady financial and clinical improvement across its hospice and home health business line. The company has recently taken […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is putting home health and hospice at the forefront of its growth sights in 2025 through a mix of strategic approaches. Aveanna has seen consecutive periods of growth in its home health and hospice business line. The company anticipates positive trends in financial and clinical outcomes to continue in the […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) plans to rejoin the fray in 2025 when it comes to acquisitions. The Atlanta-headquartered company has its eyes on targets in the private duty nursing, hospice and home health industries, according to CEO Jeff Shaner. But for this year, their emphasis will likely be on private duty and home health […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is ramping up its merger and acquisition activity in the home health and hospice space heading into next year. The Atlanta-headquartered company has set its strategic sights on both private duty nursing and hospice and home health, according to Aveanna CEO Jeff Shaner. The company has been quiet on the […]
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is focused on growth in its private duty and home health businesses in 2024, particularly through value-based contracts. The company sees this approach as a mechanism for improving hiring and building clinical capacity amid labor headwinds. Aveanna added four value-based payer contracts during Q1 for a total of 18 […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
